PPAHS releases safety checklist that targets Patient-Controlled Analgesia

NewsGuard 100/100 Score

The Physician-Patient Alliance for Health & Safety (PPAHS), an advocacy group devoted to improving patient health and safety, today announced the release of a concise checklist that reminds caregivers of the essential steps needed to be taken to initiate Patient-Controlled Analgesia (PCA) with a patient and to continue to assess that patient's use of PCA.

The checklist was developed in conjunction with renowned medical experts, including intensive care specialist and a leader in medical checklist development Peter J. Pronovost, MD, PhD, FCCM, Professor, Departments of Anesthesiology/Critical Care Medicine and Surgery, The Johns Hopkins University School of Medicine and Medical Director, Center for Innovation in Quality Patient; and Atul Gawande, MD, Professor in the Department of Health Policy and Management at the Harvard School of Public Health, who is a surgeon at Brigham and Women's Hospital Professor of Surgery at Harvard Medical School and author of "The Checklist Manifesto."

This safety checklist targeting PCA can be viewed and downloaded for free at www.ppahs.org

"Every patient in a hospital has a responsibility to work with their healthcare provider to ensure their own safety," said Michael Wong, executive director of the Physician-Patient Alliance for Health & Safety.  "That is why, with the support of noted experts, we have developed a checklist of safety procedures for healthcare providers and patients using IV PCAs.  It is through the active collaboration of physicians, nurses and patients themselves that true patient safety be achieved."

More than 56,000 adverse events and 700 patient deaths were linked to PCA pumps in reports to the Food and Drug Administration (FDA) between 2005 and 2009. One out of 378 post-surgical patients are harmed or die from errors related to the patient-controlled pumps that help relieve pain after surgical procedures, such as knee or abdominal surgery.

While research being conducted for alternatives to current PCA pumps is encouraging, for the sake of patient safety, healthcare providers should not maintain the status quo and wait for future developments.  Today's patients and their family members should ask healthcare professionals:

  • How the pump works and for a demonstration of warning signs
  • Whether the patient's oxygen levels are being monitored
  • Whether the patient is being monitored for adequacy of ventilation
  • If the patient's weight, medical conditions and other medications are being taken into account

"Hospital protocols should call for two professionals to confirm pump settings, and continuous electronically monitoring of all their patients using PCA pumps with pulse oximetry and/or capnography, along with other measures to ensure the safety of patients.  A number of centers now use capnography only to monitor ventilation in PCA patients. They have overcome the hurdles of early adoption and alarm fatigue with capnography and are showing excellent results. They have chosen to do this since they recognize the propensity for patients to be placed on supplemental oxygen and in that setting, the pulse oximeter may issue a delayed warning of critical respiratory depression," commented Frank Overdyk, MD, Executive Director for Research, North American Partners in Anesthesiology, and Professor of Anesthesiology at Hofstra University School of Medicine, who was instrumental in the development of the Checklist.  "The technology and know-how exist to reduce PCA-related incidents and deaths, and more advanced technology is being developed for the future."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses